Position
Fidelity in Enanta Pharmaceuticals Inc
Back to the book · All holders of ENTA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $53.2K$12.63 → $14.58
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.31K | $68K | — | — | — | 0.0% |
| Q1 2026 | 27.3K | $344.4K | $12.63 | −$13.5K | $290K | 0.0% |
| Q2 2026 | 29.5K | $430.2K | $14.58 | $53.2K | $32.6K | 0.0% |